Can Claude help discover treatments?

Anthropic has launched Claude Science, a new AI workbench for scientists.

It brings research tools, data and visuals into one place, making it easier for teams to organise and present their work.

The company says Claude Science could help speed up scientific research and support new healthcare treatments.

It also said several biotech and pharma companies are already using Claude.

But Anthropic is going further than just selling software. Its head of life sciences said the company wants to help discover treatments for “neglected” diseases.

That is a big move.

Most AI companies are building tools for drugmakers, while Anthropic is saying it may work on drug discovery itself.

This puts it in the same race as AI biotech startups, Big Pharma and companies like Google DeepMind’s Isomorphic Labs.

For now, details are limited. Anthropic has not said which diseases it will target first, whether it will work with labs or pharma partners, or what it would do if it finds a promising drug candidate.

Experts say “AI drug discovery” can mean many things.

AI can help find new molecules, analyse data, support trials and speed up research. But it cannot replace lab testing, human oversight or clinical trials.

AI can make parts of drug discovery faster, but medicine still takes years to test safely. New treatments must prove they work in the real world before reaching patients.

Anthropic seems to be building its life sciences team, but any real results are likely years away.

No AI-designed drug has yet gone through clinical trials and reached the market.

AI may help scientists search faster, but drugs still need to pass the real-world test.

No AI-made drug has reached the market yet, so maybe keep the champagne corked and the lab budget very, very open.- MG